Lipid implants for controlled release of biotec drugs
The invention is a lipid based implant, produced by screw extrusion. To achieve good extrudability, very homogeneous drug distribution, excellent mechanical strength, sustained release kinetics with a low burst and mainly stable modification of lipids an inventive lipid mixture has to be applied. The mixture is composed of at least 2 lipids, one of them being a high melting, solid lipid and the other a low melting point lipid. Thereby the lipid mixture can contain low
melting lipids in the form of solid, semisold or liquid lipids at room temperature. After adding the drug with a special procedure the mixture is formed into a solid implant by screw extrusion.
Further Information: PDF
Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0
Contact
Peer Biskup
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Silicon Carbide Innovation Alliance to drive industrial-scale semiconductor work
Known for its ability to withstand extreme environments and high voltages, silicon carbide (SiC) is a semiconducting material made up of silicon and carbon atoms arranged into crystals that is…
New SPECT/CT technique shows impressive biomarker identification
…offers increased access for prostate cancer patients. A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more…
How 3D printers can give robots a soft touch
Soft skin coverings and touch sensors have emerged as a promising feature for robots that are both safer and more intuitive for human interaction, but they are expensive and difficult…
